Finanzwire Finanzwire
Basculer en Français
10884 Companies
236882 Keywords
165770 Articles
127107 Press releases
Headlines Articles Press releases Zuellig Pharma Remove
  1. Home
  2. Companies
  3. Zuellig Pharma
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 12/01/2025 at 02:50, 8 months 25 days ago

    Zuellig Pharma Launches Cutting-Edge Clinical Trial Support Center in South Korea

    Automation Clinical Trials South Korea Healthcare Logistics Zuellig Pharma
  • PRESS RELEASE

    published on 12/01/2025 at 02:45, 8 months 25 days ago

    Zuellig Pharma unveils state-of-the-art Clinical Trial Support Innovation Center in South Korea to support both domestic and global clinical research needs

    Zuellig Pharma opens a state-of-the-art Clinical Trial Support Innovation Center in South Korea, enhancing clinical logistics with automation and stringent compliance standards
    Logistics Automation Healthcare Clinical Trials Zuellig Pharma
    Logo of Zuellig Pharma
  • PRESS RELEASE

    published on 08/01/2023 at 10:00, 3 years ago

    Zuellig Pharma Singapore and GSK Establish Vaccine Distribution Hub to Improve Asia’s Access to Vaccines

    Logo of Zuellig Pharma
Accesswire
  • Published on 08/26/2026 at 17:40, 13 minutes ago

    Camino Closes $5.8 Million Brokered Private Placement of Units and Concurrent $9.4 Million Non-Brokered Private Placement of Convertible Debentures

  • Published on 08/26/2026 at 15:25, 2 hours 28 minutes ago

    CF Energy Announces Financial Results for the Three-Month and Six-Month Periods Ended June 30, 2026

  • Published on 08/26/2026 at 15:00, 2 hours 53 minutes ago

    Commercial Launch Initiated for Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs

  • Published on 08/26/2026 at 15:00, 2 hours 53 minutes ago

    Arcus Announces Voting Results of the Annual General and Special Meeting

  • Published on 08/26/2026 at 14:30, 3 hours 23 minutes ago

    Klondike Gold Reports Additional Montana Creek Royalty Gold Receipts, Announces Phase 2 2026 Drill Program and Provides Exploration Update

View all ACCESSWIRE
EQS Group
  • Published on 08/26/2026 at 17:45, 8 minutes ago

    LIGHTON: Information concerning the total number of voting rights and shares in the share capital as of 31 July 2026.

  • Published on 08/26/2026 at 17:15, 38 minutes ago

    PANASONIC TOUGHBOOK CELEBRATES 30 YEARS OF FRONTLINE INNOVATION FOR MOBILE TEAMS

  • Published on 08/26/2026 at 16:55, 58 minutes ago

    Piramal Pharma Strengthens Future Ready Operations with 22.6% Emissions Reduction, 41% Renewable Energy and Zero USFDA OAI Observations

  • Published on 08/26/2026 at 16:23, 1 hour 30 minutes ago

    Original-Research: Deutsche Rohstoff AG (von First Berlin Equity Research GmbH): Buy

  • Published on 08/26/2026 at 15:31, 2 hours 22 minutes ago

    Ground-breaking ceremony for the BVB Health Centre

View all EQS
Les Echos
  • Published on 08/26/2026 at 17:40, 13 minutes ago

    First half 2026 results

  • Published on 08/25/2026 at 17:45, 1 day ago

    CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS

  • Published on 08/25/2026 at 17:45, 1 day ago

    Imerys-08-2026-information-share-capital-and-voting-rights-as-of-31-July-2026

  • Published on 08/25/2026 at 08:30, 1 day 9 hours ago

    Eiffage wins several contracts worth a total of €132 million in the healthcare sector

  • Published on 08/24/2026 at 18:00, 1 day 23 hours ago

    Outstanding shares and voting rights statement at 31 July 2026

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy